Cannabis Testing Market Accrues Phenomenally by 2026 with a Staggering CAGR

Cannabis Testing Market Accrues Phenomenally by
2026 with a Staggering CAGR
Cannabis Testing Market, by Product Type (Analytical Instruments ,
Spectroscopy Instruments, Consumables and Breathe Analyzer), by Service
Type (Potency Testing, Terpene Testing, Pesticide Testing, Residual Solvent,
Heavy Metal Testing, Mycotoxin and Microbial Testing, and Others), by End
Users (Testing Laboratories, Drug Manufactures, and Research Institutes ), and
by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and
Africa) - Size, Share, Trends and Forecast till 2026
Cannabis testing involves quantification of major chemical compound and active ingredient in the
given specimen of cannabis. Cannabinoids and terpene are major active ingredient that has medicinal
potency. Depending on the concentration of the chemical active ingredient, the potency of the sample
representing huge quantity of cannabis is decided. Cannabis testing is performed with the help of
analytical instruments such as liquid chromatography, gas chromatography etc. Commercial labs offers
dedicated cannabis testing services in developed region. Increasing number of the medicinal usage is
propelling demand for commercial manufacturing of cannabis. However, government authorities
demands quality testing of the cannabis before using them for recreational and medicinal purpose.
Market Dynamics
Cannabis testing products and services market is witnessing significant growth with increased
government approval and loosening regulatory stringent ness over use of cannabis for commercial and
recreational purpose. For instance, in February 2016, the Australian government amended the Narcotics
Drugs Act 1967, to allow cultivation of cannabis for medicinal or scientific purposes under a national

licensing scheme, which is expected to favor the growth of the commercial manufacturing of cannabis
plant in the region, which in turn would also drive growth of the cannabis testing market. Furthermore,
the Australian government in January 2018, announced that it would allow medicinal cannabis exports,
which is expected to provide growth opportunities for domestic manufacturers. Increasing number of
laboratories offering cannabis testing is expected to further drive the market growth.
Request For Sample Copy of This Business Report @
https://www.coherentmarketinsights.com/insight/request-sample/170
Legalization of cannabis for medicinal and recreational activity to drive growth of the cannabis
testing market
Increasing approval of medicinal cannabis products along with extensive research and development
activities in the medical cannabis market are expected to support growth of the cannabis testing market.
For instance, in July 2017, 18 states in the U.S. allowed the use of Cannabidiol (CBD) extract, majorly
in oil form with minimal tetrahydrocannabinol (THC) for the treatment of epilepsy or seizures in
adversely affected children. In March 2017, German parliament signed and enforced law, which allows
the healthcare professionals to prescribe the medicinal cannabis products to relieve patients from severe
health issues such as chronic pain, vomiting, and nausea.
Cannabis testing market is projected to witness positive growth during the forecast period, owing to the
requirement of desired active ingredient detection and undesired trace elements (mycotoxins and trace
metals) before utilizing cannabis product for medicinal and recreational purpose. Increased trend of
using cannabis for recreational purpose would be another major impetus for simultaneous rise in
cannabis testing market.
Increased approval for cannabis-based drugs and new product launches for cannabis testing are
expected to propel growth of the cannabis testing market
Various cannabis manufacturer across globe are focused on introducing the cannabis products to target
various disease, which in turn is expected to promote application of cannabis testing instruments, as

this products need to be approved from the health regulatory bodies for their efficacy and purity. For
instance, in May 2018, the U.S Food and Drug Administration (FDA) approved the medication, called
Epidiolex manufactured by GW Pharmaceuticals to treat two rare forms of epilepsy caused by Lennox-
Gastaut and Dravet syndromes in patients two years and older.
Key players operating in the cannabis testing market include Shimadzu Corporation, Agilent
Technologies, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Millipore Sigma, AB SCIEX
LLC, Cannabix Technologies, Inc., Waters Corporation, Steep Hill Labs, Inc., CannaSafe Analytics,
Accelerated Technology Laboratories, Inc., LabLynx, Inc., SC Laboratories Inc., GenTech Scientific,
Pharm Labs, LLC, and Digipath Labs, Inc.
expected to fuel market growth. For instance, Agilent Technologies Inc. in 2017, introduced a highresolution,
accurate gas chromatography mass system named as Agilent 7250 GC/Q-TOF system,
which combines gas chromatography and quadrupole time-of-flight mass spectrometry with a Low
Energy Electron Ionization source enabling high exploration of unknown chemical samples. Click To
Read More On Cannabis Testing Market.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com